Update on the use of pramipexole in the treatment of Parkinson's disease.

In an open label study including 25 patients, Hanna et al found no significant difference in the efficacy of pramipexole vs pergolide as adjuvant therapies in mild to moderate PD, although there was a slight trend in favour or pramipexole ( Hanna et al 2001 ).

also in 4,078 other papers